We are live on
!
Find out more
GTCM
Gyon Technologies Capital Management Portfolio holdings
AUM
$267M
1-Year Est. Return
11.62%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
-11.62%
3 Year Est. Return
+42.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$65.9M
(+22%)
Cap. Flow
+$67.5M
Cap. Flow
% of AUM
18.18%
Top 10 Holdings %
Top 10 Hldgs %
12.07%
Holding
522
New
181
Increased
107
Reduced
74
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.22M |
| 2 |
TJX Companies
TJX
|
+$4.48M |
| 3 |
AstraZeneca
AZN
|
+$4.01M |
| 4 |
Canadian National Railway
CNI
|
+$3.93M |
| 5 |
Deere & Co
DE
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$3.51M |
| 2 |
PayPal
PYPL
|
+$3.48M |
| 3 |
Acuity Brands
AYI
|
+$3.39M |
| 4 |
Pfizer
PFE
|
+$3.35M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.31% |
| 2 | Technology | 18.47% |
| 3 | Healthcare | 15.14% |
| 4 | Industrials | 12.83% |
| 5 | Consumer Discretionary | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
MongoDB
MDB
$29.8B
| $279K | 0.08% |
591
-285
| -33% | -$115K |
|
302
F5
FFIV
$23.5B
| $276K | 0.07% |
+1,390
| New | +$278K |
|
303
Genpact
G
$6.13B
| $274K | 0.07% |
+5,763
| New | +$286K |
|
304
Insmed
INSM
$28.7B
| $274K | 0.07% |
9,940
-50,356
| -84% | -$1.32M |
|
305
RTX Corp
RTX
$301B
| $273K | 0.07% |
3,179
-17,790
| -85% | -$1.52M |
|
306
Maximus
MMS
$3.06B
| $272K | 0.07% |
3,266
+703
| +27% | +$60.2K |
|
307
MDU Resources
MDU
$4.34B
| $269K | 0.07% |
+23,858
| New | +$286K |
|
308
Pool Corp
POOL
$7.31B
| $269K | 0.07% |
+619
| New | +$293K |
|
309
Universal Health Services
UHS
$10.3B
| $268K | 0.07% |
+1,935
| New | +$293K |
|
310
Pultegroup
PHM
$24.7B
| $267K | 0.07% |
+5,816
| New | +$302K |
|
311
Insulet
PODD
$9.65B
| $267K | 0.07% |
940
-1,714
| -65% | -$489K |
|
312
Murphy USA
MUSA
$9.9B
| $266K | 0.07% |
1,593
-111
| -7% | -$16.7K |
|
313
Sea Limited
SE
$68B
| $266K | 0.07% |
+836
| New | +$257K |
|
314
Netflix
NFLX
$307B
| $264K | 0.07% |
+4,320
| New | +$238K |
|
315
Sarepta Therapeutics
SRPT
$1.77B
| $262K | 0.07% |
2,832
-20,684
| -88% | -$1.59M |
|
316
H&R Block
HRB
$5.82B
| $256K | 0.07% |
+10,253
| New | +$255K |
|
|
317
Pfizer
PFE
$149B
| $256K | 0.07% |
5,954
-75,572
| -93% | -$3.35M |
|
|
SYNH
318
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $255K | 0.07% |
+2,913
| New | +$264K |
|
319
Qiagen
QGEN
$8.61B
| $254K | 0.07% |
4,633
-1,129
| -20% | -$62.9K |
|
320
White Mountains Insurance
WTM
$5.3B
| $252K | 0.07% |
236
-69
| -23% | -$77.1K |
|
|
LSXMK
321
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $250K | 0.07% |
+6,806
| New | +$250K |
|
322
United Rentals
URI
$72.4B
| $247K | 0.07% |
705
-1,050
| -60% | -$352K |
|
|
AMK
323
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $245K | 0.07% |
+9,857
| New | +$254K |
|
324
Arrow Electronics
ARW
$11.4B
| $243K | 0.07% |
2,163
+125
| +6% | +$14.5K |
|
|
ESGR
325
DELISTED
Enstar Group
ESGR
| $243K | 0.07% |
1,037
-2,347
| -69% | -$572K |
|
Similar funds
CDIA
ACMV
SCM
RW
A
CAN
JW
APP
Gyon Technologies Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Gyon Technologies Capital Management held 522 positions worth $371M, up 22% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Gyon Technologies Capital Management deployed $67.5M of net new capital in Q3 2021, opening 181 new positions and adding to 107 existing holdings. Its largest new stake was AstraZeneca: 34,466 shares worth $4.14M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $3.35M trimmed.
- Gyon Technologies Capital Management's largest Q3 2021 buy was AstraZeneca: 34,466 shares worth $4.14M.
- Gyon Technologies Capital Management added most to Microsoft in Q3 2021, an estimated $5.22M increase.
- Gyon Technologies Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.35M.
- Gyon Technologies Capital Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $3.51M.
- Gyon Technologies Capital Management's ten largest holdings make up 12% of its $371M portfolio in Q3 2021.
- Gyon Technologies Capital Management opened 181 new positions and closed 160 in Q3 2021.
- Gyon Technologies Capital Management's portfolio value rose 22% quarter-over-quarter to $371M.
Based on Gyon Technologies Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.